open access

Vol 73, No 5 (2022)
Editorial
Submitted: 2022-09-27
Accepted: 2022-09-29
Published online: 2022-10-21
Get Citation

Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. Update of the 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022 — uzupełnienie]

Jolanta Krajewska1, Ewa Chmielik2, Marek Dedecjus3, Barbara Jarząb1, Alicja Hubalewska-Dydejczyk4, Małgorzata Karbownik-Lewińska56, Beata Kos-Kudła7, Andrzej Lewiński58, Marek Ruchała9
·
Pubmed: 37067538
·
Endokrynol Pol 2022;73(5):799-802.
Affiliations
  1. Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
  2. Tumor Pathology Department, M. Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
  3. Department of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  4. Chair and Department of Endocrinology, Jagiellonian University Medical College, Kraków, Poland
  5. Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital-Research Institute, Lodz, Poland
  6. Chair and Department of Oncological Endocrinology, Medical University of Lodz, Lodz, Poland
  7. Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland
  8. Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
  9. Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland

open access

Vol 73, No 5 (2022)
Editorial
Submitted: 2022-09-27
Accepted: 2022-09-29
Published online: 2022-10-21

Abstract

N/A.

Abstract

N/A.

Get Citation
About this article
Title

Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. Update of the 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022 — uzupełnienie]

Journal

Endokrynologia Polska

Issue

Vol 73, No 5 (2022)

Article type

Editorial

Pages

799-802

Published online

2022-10-21

Page views

8310

Article views/downloads

4663

DOI

10.5603/EP.a2022.0087

Pubmed

37067538

Bibliographic record

Endokrynol Pol 2022;73(5):799-802.

Authors

Jolanta Krajewska
Ewa Chmielik
Marek Dedecjus
Barbara Jarząb
Alicja Hubalewska-Dydejczyk
Małgorzata Karbownik-Lewińska
Beata Kos-Kudła
Andrzej Lewiński
Marek Ruchała

References (4)
  1. Jarząb B, Dedecjus M, Lewiński A, et al. Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych - Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022]. Endokrynol Pol. 2022; 73(2): 173–300.
  2. Endocrine and Neuroendocrine tumours. In: WHO Classification of Tumours. Cree I., Denton E., Field A. et al. (eds). International Agency for Research on Cancer: Lyon, France 2022 . https://tumourclassification.iarc.who.int/chapters.
  3. Baloch ZW, Asa SL, Barletta JA, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022; 33(1): 27–63.
  4. Brose M, Robinson B, Sherman S, et al. Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2021; 22(8): 1126–1138.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl